{
  "docId": "019de073-f021-770f-8b07-e7c119465e03",
  "docSlug": "6227ea40012eb82f352898e4936ae469",
  "documentTitle": "Bausch Health Companies | Results Presentation Deck | 48 slides",
  "authorId": "bausch-health-companies",
  "authorName": "Bausch Health",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.2938006,
  "pageNumber": 30,
  "pageCount": 48,
  "prevPage": 29,
  "nextPage": 31,
  "slideType": "appendix_data",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 40,
  "notes": "Includes footnotes regarding non-GAAP measures, share counts, and exclusions for cash flow.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-f021-770f-8b07-e7c119465e03/30",
  "deckHref": "/decks/019de073-f021-770f-8b07-e7c119465e03",
  "deckJsonHref": "/decks/019de073-f021-770f-8b07-e7c119465e03.json",
  "deckAnchorHref": "/decks/019de073-f021-770f-8b07-e7c119465e03#slide-30",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.91,
        "x": 0.045,
        "y": 0.81
      },
      "kind": "disclaimer",
      "text": "1. This is a non-GAAP measure or non-GAAP ratio. See Slide 3 and Non-GAAP Appendix for further information on non-GAAP measures and ratios. 2. See Appendix for details on amortization and impairments of intangible assets. 3. This figure includes the dilutive impact of options and restricted stock units of approximately 1,906,000 and 5,221,000 common shares for the nine months ended September 30, 2022 and 2021, respectively, which are excluded when calculating GAAP diluted loss per share because the effect of including the impact in this calculation would have been anti-dilutive. 4. Excludes legacy legal settlements (net of insurance recoveries), separation payments, separation-related payments, IPO payments and IPO-related payments and net cash provided by Amoun operating activities.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "71cb1db2-5a14-475e-8aaa-3f7111bc0597",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.91,
        "x": 0.045,
        "y": 0.163
      },
      "kind": "table",
      "text": "Financial results table comparing 9.30.22 and 9.30.21 metrics",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "769d0df4-d2bb-4c62-a34f-98c3dc0be4d2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.45,
        "x": 0.045,
        "y": 0.055
      },
      "kind": "title",
      "text": "Consolidated YTD Non-GAAP financial results",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e842651f-93b8-4ff0-a7ad-f55a4ccb567e",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "5f53a0a5-b743-47df-90f1-8f226c7b6603",
      "evidence": "table/data: Financial results table comparing 9.30.22 and 9.30.21 metrics",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}